Childhood Leukemia — Trials

Childhood Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

473 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 79
Recruiting: 50
Ph III recruiting: 2
Growth YoY: −38.1%
Industry share: 6%
Top sponsor: Nationwide Children's Hospital
Termination share: 19.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03241940	Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies	active not recruiting	Phase 1	33	Stanford UniversityOTHER	1	Jun 30, 2026	clinicaltrials
NCT03817320	PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma	active not recruiting	Phase 1 / Phase 2	24	Therapeutic Advances in Childhood Leukemia ConsortiumOTHER	2	Jun 17, 2025